FDA Approved: BASAGLAR KWIKPEN — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly in an Original Application as a long-acting insulin for glycemic control in adults with diabetes m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• BASAGLAR KWIKPEN (Insulin glargine)

Snippet

ORIG AP for BASAGLAR KWIKPEN (INSULIN GLARGINE)